TY - JOUR
T1 - A study of pericardial effusion in HIV positive patients and its correlation with the CD4 count
AU - Sharath, Madhyastha P.
AU - Reddy, Charan Thej
AU - Shetty, Ganesh V.
AU - Shastry, Barkur Ananthakrishna
AU - Doddamani, Akhila
N1 - Funding Information:
We acknowledge the department of cardiology for providing echocardiography reports.
Publisher Copyright:
© 2021 the University of Health Sciences Turkey, Gülhane Faculty of Medicine / Gülhane Medical Journal published by Galenos Publishing House. All Rights Reserved.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/3
Y1 - 2021/3
N2 - Aims: Cardiovascular diseases in human immunodeficiency virus (HIV)-positive patients are becoming increasingly detected in developing countries and pericardial effusion is one of the common problems amongst them. The relation of CD4 count is also important, as it correlates with the severity of cardiac involvement. The present study was therefore undertaken to determine the clinical profile of pericardial effusion in HIV patients and its correlation with CD4 count. Methods: This cross-sectional study was conducted in a tertiary care hospital from 2015 to 2017 and it included 500 HIV patients, 39 of whom had pericardial effusion. All patients were assessed clinically and had undergone electrocardiograph, echocardiography and CD4 count along with the routine investigations. The presence of pericardial effusion was determined by echocardiography. The pericardial fluid was analyzed for cells, biochemistry, Gram staining, AFB staining and cultures. An attempt was made to correlate the findings with CD4 count. Results: Out of 500 HIV-positive patients, 39 (7.8%) were found to have pericardial effusion. Majority were male (64.1%) and middle-aged (40-65 y/o) (59%). Most of the effusions (61.54%) were quantified as large and the most common etiology was tuberculous (41%). Twenty-one patients (53.85%) were in the subgroup of CD4 count <50 cells/^L and 16 of them had severe pericardial effusion. Sixty-four percent of the patients underwent pericardial drainage and the remaining were managed medically. Conclusions: In the present study, 7.8% of HIV-infected patients had pericardial effusion. Tuberculosis is the most common cause. The lower the CD4 count is, the larger the pericardial effusion will be.
AB - Aims: Cardiovascular diseases in human immunodeficiency virus (HIV)-positive patients are becoming increasingly detected in developing countries and pericardial effusion is one of the common problems amongst them. The relation of CD4 count is also important, as it correlates with the severity of cardiac involvement. The present study was therefore undertaken to determine the clinical profile of pericardial effusion in HIV patients and its correlation with CD4 count. Methods: This cross-sectional study was conducted in a tertiary care hospital from 2015 to 2017 and it included 500 HIV patients, 39 of whom had pericardial effusion. All patients were assessed clinically and had undergone electrocardiograph, echocardiography and CD4 count along with the routine investigations. The presence of pericardial effusion was determined by echocardiography. The pericardial fluid was analyzed for cells, biochemistry, Gram staining, AFB staining and cultures. An attempt was made to correlate the findings with CD4 count. Results: Out of 500 HIV-positive patients, 39 (7.8%) were found to have pericardial effusion. Majority were male (64.1%) and middle-aged (40-65 y/o) (59%). Most of the effusions (61.54%) were quantified as large and the most common etiology was tuberculous (41%). Twenty-one patients (53.85%) were in the subgroup of CD4 count <50 cells/^L and 16 of them had severe pericardial effusion. Sixty-four percent of the patients underwent pericardial drainage and the remaining were managed medically. Conclusions: In the present study, 7.8% of HIV-infected patients had pericardial effusion. Tuberculosis is the most common cause. The lower the CD4 count is, the larger the pericardial effusion will be.
UR - http://www.scopus.com/inward/record.url?scp=85101922082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101922082&partnerID=8YFLogxK
U2 - 10.4274/gulhane.galenos.2020.1216
DO - 10.4274/gulhane.galenos.2020.1216
M3 - Article
AN - SCOPUS:85101922082
SN - 1302-0471
VL - 63
SP - 20
EP - 24
JO - Gulhane Medical Journal
JF - Gulhane Medical Journal
IS - 1
ER -